Design and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives bearing an imidazolone moiety as c-Met kinase inhibitors

A series of novel 4-(2-fluorophenoxy)quinoline derivatives containing imidazolone moiety designed, synthesized and evaluated for their enzymatic assays, cytotoxicity and docking analysis.129